Valuation GlaxoSmithKline Pharmaceuticals Limited

Stocks

Delayed Bombay S.E. Other stock markets 12:21:47 2026-07-08 am EDT			5-day change	1st Jan Change
2,403.75 ^INR	+0.04%		-1.92%	-2.72%

May. 29	GlaxoSmithKline Pharmaceuticals Limited Announces Resignation of Dr. Simrat Sohal from Compliance Officer and Ceases to Be the Senior Management Personnel, Effective August 5, 2026	CI
May. 13	GlaxoSmithKline Pharmaceuticals Clocks Higher Fiscal Q4 Consolidated Net Profit	MT

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	281,714	224,319	329,173	487,432	386,822	407,066	-
Change	-	-20.37%	46.74%	48.08%	-20.64%	5.23%	-
Enterprise Value (EV)	256,351	207,663	329,173	487,432	386,822	407,066	407,066
Change	-	-18.99%	58.51%	48.08%	-20.64%	5.23%	0%
P/E	16.6x	36.7x	55.8x	52.5x	37.3x	35.3x	31.1x
PBR	10.6x	12.9x	18.5x	25x	17.1x	15.3x	13x
PEG	-	-0.6x	-16.49x	0.9x	3.2x	3.2x	2.3x
Capitalization / Revenue	8.59x	6.9x	9.53x	13x	10.1x	9.71x	8.76x
EV / Revenue	0x	0x	0x	0x	0x	9.71x	8.76x
EV / EBITDA	0x	0x	0x	0x	0x	27.7x	24.4x
EV / EBIT	0x	0x	0x	0x	0x	29.6x	25.9x
EV / FCF	0x	0x	0x	0x	0x	35.1x	31.7x
FCF Yield	2.75%	1.96%	1.67%	2.6%	2.19%	2.85%	3.16%
Dividend per Share ²	30	32	32	42	57	29.5	29.5
Rate of return	1.8%	2.42%	1.65%	1.46%	2.5%	1.23%	1.23%
EPS ²	100	36.05	34.83	54.76	61.15	67.98	77.28
Distribution rate	30%	88.8%	91.9%	76.7%	93.2%	43.4%	38.2%
Net sales ¹	32,780	32,517	34,537	37,492	38,217	41,939	46,453
EBITDA ¹	8,273	8,043	9,087	11,774	13,092	14,683	16,675
EBIT ¹	7,592	7,385	8,390	11,106	12,428	13,760	15,728
Net income ¹	16,947	6,107	5,900	9,276	10,360	11,515	12,873
Net Debt	-25,363	-16,656	-	-	-	-	-
Reference price ²	1,662.95	1,324.15	1,943.10	2,877.30	2,283.40	2,402.90	2,402.90
Nbr of stocks (in thousands)	169,406	169,406	169,406	169,406	169,406	169,406	-
Announcement Date	5/16/22	5/17/23	5/17/24	5/13/25	5/13/26	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
GLAXOSMITHKLINE PHARMACEUTICALS LIMITED	35.67x	-	-	1.23%	4.26B
ELI LILLY AND COMPANY	35.08x	12.75x	25.97x	0.57%	1,070B
JOHNSON & JOHNSON	27.67x	6.37x	17.29x	2.06%	624B
ABBVIE INC.	31.08x	7.52x	15.39x	2.69%	450B
ROCHE HOLDING AG	17.65x	4.4x	10.87x	3.02%	328B
NOVARTIS AG	21.61x	5.56x	13.43x	2.84%	284B
NOVO NORDISK A/S	14.17x	5.28x	10.84x	3.53%	217B
AMGEN INC.	23.97x	6.34x	11.16x	2.75%	198B
GILEAD SCIENCES, INC.	-45.95x	5.59x	31.09x	2.5%	161B
PFIZER INC.	11.55x	2.99x	7.34x	7.38%	135B
Average	17.25x	6.31x	15.93x	2.86%	347.17B
Weighted average by Cap.	23.87x	8.00x	18.30x	2.19%